Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer

被引:133
作者
Ferrer, Montserrat [1 ,2 ]
Francisco Suarez, Jose [3 ]
Guedea, Ferran [4 ]
Fernandez, Pablo [5 ]
Macias, Victor [6 ]
Marino, Alfonso [7 ]
Hervas, Asuncion [8 ]
Herruzo, Ismael [9 ]
Jose Ortiz, Maria [10 ]
Villavicencio, Humberto [11 ]
Craven-Bratle, Jordi [12 ]
Garin, Olatz [1 ,2 ]
Aguilo, Ferran
机构
[1] Hosp del Mar, IMIM, Unitat Recerca Serv Sanit, Barcelona 08003, Spain
[2] CIBER Epidemiol & Salud Publ, Barcelona, Spain
[3] Hosp Univ Bellvitge, Serv Urol, Lhospitalet De Llobregat, Spain
[4] Inst Catala Oncol, Serv Oncol Radioterap, Lhospitalet De Llobregat, Spain
[5] Inst Oncol Guipuzcoa, Serv Oncol Radioterap, San Sebastian, Spain
[6] Capio Hosp Gen Catalunya, Serv Oncol Radioterap, Sant Cugat Del Valles, Spain
[7] Ctr Oncol Galicia, Serv Oncol Radioterap, La Coruna, Spain
[8] Hosp Ramon & Cajal, Serv Oncol Radioterap, E-28034 Madrid, Spain
[9] Hosp Reg Carlos Haya, Serv Oncol Radioterap, Malaga, Spain
[10] Hosp Virgen Del Rocio, Serv Oncol Radioterap, Seville, Spain
[11] Fdn Puigvert, Serv Urol, Barcelona, Spain
[12] Hosp Santa Creu & Sant Pau, Serv Oncol Radioterap, Barcelona, Spain
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 02期
关键词
quality of life; radical prostatectomy; external beam radiotherapy; prostate brachytherapy; EPIC;
D O I
10.1016/j.ijrobp.2007.12.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To compare treatment impact on health-related quality of life (HRQL) in patients with localized prostate cancer, from before treatment to 2 years after the intervention. Methods and Materials: This was a longitudinal, prospective study of 614 patients with localized prostate cancer treated with radical prostatectomy (134), three-dimensional external conformal radiotherapy (205), and brachytherapy (275). The HRQL questionnaires administered before and after treatment (months 1, 3,6,12, and 24) were the Medical Outcomes Study 36-Item Short Form, the Functional Assessment of Cancer Therapy (General and Prostate Specific), the Expanded Prostate Cancer Index Composite (EPIC), and the American Urological Association Symptom Index. Differences between groups were tested by analysis of variance and within-group changes by univariate repeated-measures analysis of variance. Generalized estimating equations (GEE) models were constructed to assess between-group differences in HRQL at 2 years of follow-up after adjusting for clinical variables. Results: In each treatment group, HRQL initially deteriorated after treatment with subsequent partial recovery. However, some dimension scores were still significantly lower after 2 years of treatment. The GEE models showed that, compared with the brachytherapy group, radical prostatectomy patients had worse EPIC sexual summary and urinary incontinence scores (-20.4 and -14.1; p < 0.001), and external radiotherapy patients had worse EPIC bowel, sexual, and hormonal summary scores (-3.55, -5.24, and -1.94; p < 0.05). Prostatectomy patients had significantly better EPIC urinary irritation scores than brachytherapy patients (+4.16; p < 0.001). Conclusions: Relevant differences between treatment groups persisted after 2 years of follow-up. Radical prostatectomy had a considerable negative effect on sexual functioning and urinary continence. Three-dimensional conformal radiotherapy had a moderate negative impact on bowel functioning, and brachytherapy caused moderate urinary irritation. These results provide relevant information for clinical decision making. (c) 2008 Elsevier Inc.
引用
收藏
页码:421 / 432
页数:12
相关论文
共 46 条
[1]  
ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771
[2]  
[Anonymous], 2004, SUDAAN LANG MAN REL
[3]  
[Anonymous], AJCC CANC STAGING MA
[4]  
Badia X, 1997, EUR UROL, V31, P129
[5]   Validation of a harmonized Spanish version of the IPSS:: Evidence of equivalence with the original American scale [J].
Badía, X ;
García-Losa, M ;
Dal-Ré, R ;
Carballido, J ;
Serra, M .
UROLOGY, 1998, 52 (04) :614-620
[6]   Clinical impact of implementing the recommendations of AAPM task group 43 on permanent prostate brachytherapy using 125I [J].
Bice, WS ;
Prestidge, BR ;
Prete, JJ ;
Dubois, DF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (05) :1237-1241
[7]   Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results [J].
Borchers, H ;
Kirschner-Hermanns, R ;
Brehmer, B ;
Tietze, L ;
Reineke, T ;
Pinkawa, M ;
Eble, MJ ;
Jakse, G .
BJU INTERNATIONAL, 2004, 94 (06) :805-811
[8]   Serum PSA correlates more strongly with percentage of cancer and cancer volume than with prostate size [J].
Catalona, WJ ;
Yu, XY ;
Roehl, KA ;
Yeh, JT ;
Gashti, SN ;
Antenor, JAV ;
Han, M .
JOURNAL OF UROLOGY, 2005, 173 (04) :257-257
[9]   The PSA era is not over for prostate cancer [J].
Catalona, WJ ;
Loeb, S .
EUROPEAN UROLOGY, 2005, 48 (04) :541-545
[10]   COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE-SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE-CANCER - RESULTS OF A MULTICENTER CLINICAL-TRIAL OF 6,630 MEN [J].
CATALONA, WJ ;
RICHIE, JP ;
AHMANN, FR ;
HUDSON, MA ;
SCARDINO, PT ;
FLANIGAN, RC ;
DEKERNION, JB ;
RATLIFF, TL ;
KAVOUSSI, LR ;
DALKIN, BL ;
WATERS, WB ;
MACFARLANE, MT ;
SOUTHWICK, PC .
JOURNAL OF UROLOGY, 1994, 151 (05) :1283-1290